Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer PFE.N COVID-19 treatment Paxlovid, ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
Shiba Inu price remains steady this week, reflecting the broader crypto market trend. The SHIB is trading above $0.00002, ...
Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of ...
The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.